Top Medical News
Tristan Manalac, 2 hours ago
In South and Southeast Asia, children younger than 12 months of age, with comorbidities, or who present with coughs are more likely to develop severe episodes of the novel coronavirus disease (COVID-19), according to a recent study.
3 hours ago
Chronic kidney disease (CKD) patients prescribed potentially inappropriate medications (PIMs) risk falling, being hospitalized, and dying, with the greatest risk occurring among those who have more than one PIM prescription, as shown in a study.
3 hours ago
The hepatitis E virus (HEV) seems to persist in the ejaculate of chronically infected men who are immunosuppressed, a recent study has found.
Roshini Claire Anthony, 17 hours ago

Children with uncontrolled moderate-to-severe asthma may benefit from treatment with dupilumab which reduced exacerbations and improved lung function, according to results of the phase III VOYAGE study presented at ATS 2021.

Jairia Dela Cruz, 21 hours ago
Women with shorter pregnancy duration are likely to develop haemorrhagic or ischaemic stroke in the future, with the risk remaining elevated at least 40 years later, a large study has found.
22 hours ago
Water-aided techniques (WT), particularly the water exchange (WE) method, help enhance serrated polyp detection rate (SPDR) during colonoscopy, a study has shown.
Stephen Padilla, 23 hours ago
Low to moderate alcohol consumption may lower the likelihood of incident cataract that requires surgery, suggests a recent study of two large UK cohorts. Furthermore, this relationship is most evident for the consumption of polyphenol-rich wine.
Special Reports
16 Jun 2021
Ceftaroline fosamil 600 mg powder for infusion
16 Jun 2021
Perindopril arginine 3.5 mg,
Amlodipine besilate 2.5 mg tab
16 Jun 2021
Furfuryl Palmitate
16 Jun 2021
Letermovir 240 mg film-coated tab and infusion conc
06 May 2021
In a webinar held on 27 March 2021, paediatric endocrinology nurses Karen Blair, Kate Davies, and Siti Zarina Yaakop shared insights and clinical experience based on their frontline roles in caring for patients with central precocious puberty (CPP) and supporting their family members.
Dr. Karl Csaky, Dr. Charles Wykoff, Dr. Jeffrey Heier, 08 Apr 2021
Intravitreal injections with anti-vascular endothelial growth factor (VEGF) agents are associated with significant treatment burden for patients with diabetic macular oedema (DME) and neovascular age-related macular degeneration (nAMD). At the Angiogenesis, Exudation, and Degeneration 2021 Virtual Congress, Dr Karl Csaky of Retina Foundation of the Southwest, Dallas, Texas, US, Dr Charles Wykoff of Retina Consultants of Texas, Houston, Texas, US, and Dr Jeffrey Heier of Ophthalmic Consultants of Boston, Boston, Massachusetts, US, presented results of four phase III trials that compared the efficacy and safety of the investigational bispecific antibody, faricimab, administered at up to Q16W dosing intervals, vs the decoy VEGF-A/placental growth factor (PIGF) receptor aflibercept at Q8W dosing intervals, in patients with retinal vascular diseases.
Prof. David Paterson, 30 Mar 2021
Intensive care unit (ICU) patients are at risk of developing serious infections with multidrug-resistant organisms (MDROs), which require appropriate and adequate antibiotic coverage. Early empirical coverage is pivotal in saving patients’ lives. At a recent webinar co-organized by the Society of Infectious Disease (Singapore) and Pfizer, renowned Professor David Paterson, Professor of Medicine and Director, The University of Queensland Centre for Clinical Research, and Consultant Infectious Diseases Physician, Royal Brisbane and Women’s Hospital, Brisbane, Australia, discussed the role of newer antimicrobial agents, including ceftazidime-avibactam (Zavicefta) in the management of MDROs in the ICU. Dr Wong Sin Yew, Infectious Disease Physician at Gleneagles Medical Centre and Mount Elizabeth Novena Specialist Centre, Singapore, chaired the event.
Conference Reports
Roshini Claire Anthony, 22 Jun 2021

Children with uncontrolled moderate-to-severe asthma may benefit from treatment with dupilumab which reduced exacerbations and improved lung function, according to results of the phase III VOYAGE study presented at ATS 2021.

Elaine Soliven, 22 Jun 2021
A new infant formula supplemented with bioactive nutrients — containing MFGM* components, LC-PUFAs**, and synbiotics — may improve neurocognitive function and brain development in healthy children at 6 years of age, according to the COGNIS*** study presented at WCPGHAN 2021.
Roshini Claire Anthony, 21 Jun 2021

Individuals with familial dementia (FD), defined as dementia in a first-degree relative, which confers an increased risk of dementia, could reduce their risk by adopting a healthy lifestyle, a study presented at the American Heart Association (AHA) Epidemiology, Prevention, Lifestyle & Cardiometabolic Health Conference 2021 showed.

Elvira Manzano, 21 Jun 2021
The fractional flow reserve (FFR) approach is no better than angiography-guided strategy in patients with multivessel STEMI* undergoing complete revascularization in the head-to-head FLOWER-MI trial**.
Audrey Abella, 21 Jun 2021
A novel anti-regurgitation (AR) formula combining carob bean gum (CBG) with prebiotics and postbiotics was found to have a more pronounced benefit for infants with more severe gastrointestinal (GI) symptoms, according to the results of a post hoc analysis presented at WCPGHAN 2021.
Pearl Toh, 19 Jun 2021
Certain therapies used for rheumatic diseases, including rituximab, are associated with worse outcomes for COVID-19 and reduced immune response after COVID-19 vaccination in patients with rheumatic diseases, according to two studies presented at the virtual EULAR 2021 Congress.
Roshini Claire Anthony, 18 Jun 2021

Treatment with the fully human anti-IL17 monoclonal antibody secukinumab resulted in fewer, and a longer time to, disease flares in children and adolescents with enthesitis-related arthritis (ERA) and juvenile psoriatic arthritis (JPsA), results of the phase III JUNIPERA trial showed.